• Citer

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

par Pachl, Jan;Svoboda, Petr;Jacobs, Frédérique ;Vandewoude, K;van der Hoven, Ben;Spronk, Peter;Masterson, Gary;Malbrain, Manu;Aoun, Michel ;Garbino, Jorge;Takala, Jukka;Drgona, L.;Burnie, James;Matthews, Ruth;Mycograb Invasive Candidiasis Study Group,
Référence Clinical infectious diseases, 42, 10, page (1404-1413)
Publication Publié, 2006-05

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.
Auteur:	Pachl, Jan; Svoboda, Petr; Jacobs, Frédérique; Vandewoude, K; van der Hoven, Ben; Spronk, Peter; Masterson, Gary; Malbrain, Manu; Aoun, Michel; Garbino, Jorge; Takala, Jukka; Drgona, L.; Burnie, James; Matthews, Ruth; Mycograb Invasive Candidiasis Study Group,
Informations sur la publication:	Clinical infectious diseases, 42, 10, page (1404-1413)
Statut de publication:	Publié, 2006-05
Sujet CREF:	Cancérologie
MeSH keywords:	Adult
	Aged
	Amphotericin B -- therapeutic use
	Antibodies, Monoclonal -- therapeutic use
	Antifungal Agents -- therapeutic use
	Candida -- classification -- isolation & purification
	Candidiasis -- drug therapy -- physiopathology
	Double-Blind Method
	Female
	HSP90 Heat-Shock Proteins -- antagonists & inhibitors
	Humans
	Male
	Middle Aged
	Patient Selection
	Placebos
	Recombinant Proteins -- therapeutic use
	Treatment Outcome
Note générale:	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1058-4838
	info:doi/10.1086/503428
	info:pii/CID38863
	info:scp/33646455866
	info:pmid/16619152